Bone Conduction Implants Market: Increasing incidence of disabling hearing loss to drive the market

Bone conduction implants are medical devices that conduct sound through bone conduction implants by using the natural ability of the human body.

Albany NY, United States: Global Bone Conduction Implants Market: Overview

Bone conduction implants are medical devices that conduct sound through bone conduction implants by using the natural ability of the human body. Bone conduction implants are generally used by individuals affected by conductive hearing loss, mixed hearing, or single-side deafness. Different kinds of bone conduction implants devices (BCDs) are available for hearing rehabilitation. Hearing loss can result from certain infectious diseases, exposure to excessive noise, genetic causes, chronic ear infections or complications at birth. Also, problems associated with hearing is one of the major issues faced by the elderly population (people aged 60 years or above).

Read Report Overview - https://www.transparencymarketresearch.com/bone-conduction-implants-market.html

Global Bone Conduction Implants Market: Drivers and Restraints

Increasing incidence of disabling hearing loss, growing elderly population, wide availability of technologically advanced products, and increasing prevalence of chronic ear infections are some of the factors likely to drive the bone conduction implants market during the forecast period. According to the World Health Organization, in 2016, 360 million people worldwide suffered from disabling hearing loss and 32 million of these were children. Unaddressed hearing loss across the globe costs approximately US$ 70 Bn annually. Also, 1.1 billion youngsters (people aged between 12 and 35 years) are at a risk of hearing loss due to exposure to noise in recreational settings. According to the U.S. Census Bureau, in 2016, 8.5% of people across the world (617 million) were aged 65 years or above and the number is projected to increase to nearly 17% by 2050 (1.6 billion).

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41120

Global Bone Conduction Implants Market: Key Segments

The bone conduction implants market can be segmented based on product, type of implant, application, end-user, and geography. Based on product, the market has been segmented into skin drive devices and direct drive devices. The skin drive devices segment has been sub-divided into conventional devices and passive transcutaneous devices. The direct drive devices segment has been sub-segmented into percutaneous devices and active transcutaneous devices. Based on type of implant, the bone conduction implants market has been classified into active implants and passive implants. Based on application, the market has been segregated into conductive hearing loss, single-sided deafness, and others. Based on end-user, the bone conduction implants market has been divided into hospitals, specialty clinics, and others.

Request for Analysis of COVID-19 Impact on Bone Conduction Implants Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=41120

Based on geography, the global bone conduction implants market has been segmented into five regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2016. Increasing prevalence of hearing loss among children and elderly people and presence of key market players in the region are some of the factors likely to drive the bone conduction implants market in North America during the forecast period. According to Hearing Loss Association of America, two to three of every 1,000 children in the U.S. are born with detectable hearing loss in one or both ears. Europe is expected to account for the second-largest share of the global bone conduction implants market during the forecast period. Growth of the bone conduction implants market in the region is attributable to favorable reimbursement policies and increasing adoption of technologically advanced products in the region. According to the National Institute for Health and Disability Insurance, public expenditure on hearing aids reimbursement in Belgium is around US$ 22.7 Mn per year, for approximately 40,000 devices. Reimbursement in the country is based on a fixed lump-sum of US$ 569 for unilateral devices and around US$ 1,081.9 for bilateral devices. The bone conduction implants market in Asia Pacific is expected to register a high growth rate from 2017 to 2025, due to development of health care infrastructure, rise in disposable incomes, growth of elderly population in countries such as India and China, and economic development of the region. According to United Nations ESCAP, the Asia Pacific region is currently home to about 60% of the world’s elderly population. The number of elderly people in the region is expected to get more than double, from 547 million in 2016 to nearly 1.3 billion by 2050.

Pre Book Bone Conduction Implants Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=41120&ltype=S

Global Bone Conduction Implants Market: Key Players

Some of the key players operating in the global bone conduction implants market are Cochlear Ltd., Medtronic, Siemens Healthineers, and Sonova.

More Trending Reports by Transparency Market Research:

Extracorporeal Membrane Oxygenation Machine Market Extracorporeal membrane oxygenation, also known as extracorporeal life support, is an extracorporeal technique of providing prolonged cardiac and respiratory support to persons whose heart and lungs are unable to provide an adequate amount of gas exchange or perfusion to sustain life. Nowadays extracorporeal membrane oxygenation machine has become more reliable with improvement in equipment.

Biological Safety Testing Market As per the business intelligence report by the Transparency Market Research, the global biological safety testing market is expected to arise from its last evaluation of US$ 1.31 billion at the beginning of the forecast period i.e. 2015 to hit the mark of US$ 3.08 billion at the end of the forecast period i.e. in 2024. The research report also predicts that the global biological safety testing market will expand at a stellar growth rate of 10 % over the forecast period of 2016 to 2024.

Montelukast API Market Montelukast is a leukotriene inhibitor prescribed to prevent asthma attacks in adults as well as children aged at least two years old. It is also used to prevent exercise-induced bronchoconstriction, primary dysmenorrhea, hay fever, and allergic rhinitis. Montelukast can help to reduce the number of times medication is used for quick relief. In 2019, the allergic rhinitis segment dominated the global montelukast sodium market. Allergic rhinitis, often known as hay fever, is a form of nasal inflammation.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Rohit Bhisey
Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/